Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
American Industrial Partners (AIP) will acquire Avanos Medical in a go-private transaction valued at $1.27 billion. Avanos accepted the offer and AIP agreed to pay a 72.1% premium to Avanos’ closing stock price on Monday.
Avanos reported $701.2 million in net sales in 2025 and forecast 2026 net sales between $700 million and $720 million. The company competes in specialty nutrition systems and pain management, with specialty nutrition systems generating $432.9 million in net sales in 2025 and pain sales totaling $237.8 million.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026